Earnings Update: Helmerich & Payne, Inc. (NYSE:HP) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts

Helmerich & Payne, Inc.

Helmerich & Payne, Inc.

HP

0.00

Last week, you might have seen that Helmerich & Payne, Inc. (NYSE:HP) released its quarterly result to the market. The early response was not positive, with shares down 7.1% to US$37.78 in the past week. It was a pretty bad result overall; while revenues were in line with expectations at US$932m, statutory losses exploded to US$0.59 per share. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

earnings-and-revenue-growth
NYSE:HP Earnings and Revenue Growth May 11th 2026

Following last week's earnings report, Helmerich & Payne's eleven analysts are forecasting 2026 revenues to be US$3.96b, approximately in line with the last 12 months. The loss per share is expected to greatly reduce in the near future, narrowing 56% to US$1.64. Before this earnings announcement, the analysts had been modelling revenues of US$3.98b and losses of US$1.09 per share in 2026. While this year's revenue estimates held steady, there was also a regrettable increase in loss per share expectations, suggesting the consensus has a bit of a mixed view on the stock.

The consensus price target held steady at US$39.47, seemingly implying that the higher forecast losses are not expected to have a long term impact on the company's valuation. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. Currently, the most bullish analyst values Helmerich & Payne at US$47.00 per share, while the most bearish prices it at US$30.00. This shows there is still a bit of diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation.

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. These estimates imply that revenue is expected to slow, with a forecast annualised decline of 1.9% by the end of 2026. This indicates a significant reduction from annual growth of 22% over the last five years. By contrast, our data suggests that other companies (with analyst coverage) in the same industry are forecast to see their revenue grow 5.6% annually for the foreseeable future. So although its revenues are forecast to shrink, this cloud does not come with a silver lining - Helmerich & Payne is expected to lag the wider industry.

The Bottom Line

The most important thing to take away is that the analysts increased their loss per share estimates for next year. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. The consensus price target held steady at US$39.47, with the latest estimates not enough to have an impact on their price targets.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for Helmerich & Payne going out to 2028, and you can see them free on our platform here..